Remove 2001 Remove Chronic Pain Remove Consumption Remove Terpenes
article thumbnail

Best strains and terpenes for migraine relief

The Cannigma

Based on the limited existing evidence, the best cannabis strain for migraines may be a Type II that includes both THC and CBD, and a terpene profile that includes beta-caryophyllene, myrcene, linalool, limonene, bisabolol, humulene or pinene. The study called out pinene, myrcene, and beta-caryophyllene as specifically useful terpenes.

Terpenes 132
article thumbnail

Pushing Cannabis into Modern Healthcare

CannaTech

Canada has been at the forefront of shaping much of the rhetoric surrounding cannabis since 2001. But this gap restricts patient access to a medicine that can offer relief to a long list of conditions including chronic pain, seizures attributed to epilepsy, as well as mood disorders such as anxiety and depression.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cannabis as Medicine: 101

Puff Puff Post

This brought the legislative act known as the Medical Marijuana Access and Resources (MMAR) into legislature on July 30 th , 2001 permitted patients access to cannabis for medicinal purposes, from Licensed Producers approved by Health Canada. may negatively impact the reproductive organs and it functions for both males and females.

article thumbnail

The Endocannabinoid System-History, Health and Why We Feel High

Puff Puff Post

On July 30 th , 2001, the government brought this into a legislative act known as the Medical Marijuana Access and Resources (MMAR). The cannabis plant is composed of thousands of biologically active molecules which not only include phytocannabinoids, but also include terpenes and flavonoids. Some well researched terpenes include: .

History 94
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Only one article appeared in the MJA in 2000 and again in 2001. Conclusions. This offers a more denotative approach to complement the data.